Correlation Between Crispr Therapeutics and Migdal Mutual
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Migdal Mutual at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Migdal Mutual into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Migdal Mutual Funds, you can compare the effects of market volatilities on Crispr Therapeutics and Migdal Mutual and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Migdal Mutual. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Migdal Mutual.
Diversification Opportunities for Crispr Therapeutics and Migdal Mutual
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Crispr and Migdal is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Migdal Mutual Funds in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Migdal Mutual Funds and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Migdal Mutual. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Migdal Mutual Funds has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Migdal Mutual go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Migdal Mutual
Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 10.86 times more return on investment than Migdal Mutual. However, Crispr Therapeutics is 10.86 times more volatile than Migdal Mutual Funds. It trades about 0.03 of its potential returns per unit of risk. Migdal Mutual Funds is currently generating about 0.07 per unit of risk. If you would invest 5,108 in Crispr Therapeutics AG on January 19, 2024 and sell it today you would earn a total of 506.00 from holding Crispr Therapeutics AG or generate 9.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 80.72% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Migdal Mutual Funds
Performance |
| Timeline |
| Crispr Therapeutics |
| Migdal Mutual Funds |
Crispr Therapeutics and Migdal Mutual Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Migdal Mutual
The main advantage of trading using opposite Crispr Therapeutics and Migdal Mutual positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Migdal Mutual can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Migdal Mutual will offset losses from the drop in Migdal Mutual's long position.| Crispr Therapeutics vs. Home Federal Bancorp | Crispr Therapeutics vs. Betterware De Mexico | Crispr Therapeutics vs. Provident Bancorp | Crispr Therapeutics vs. Heartland Financial USA |
| Migdal Mutual vs. Migdal Mutual Funds | Migdal Mutual vs. Migdal Mutual Funds | Migdal Mutual vs. Migdal Mutual Funds | Migdal Mutual vs. Migdal Mutual Funds |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |